gossypin

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namegossypin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsSerine/threonine-protein kinase B-raf inhibitors
TargetsCyclin-dependent kinase 4Serine/threonine-protein kinase B-raf
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTexas Biomedical Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTexas Biomedical Research Institute
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A